Clinical significance of interstitial lung abnormalities and immune checkpoint <scp>inhibitor‐induced</scp> interstitial lung disease in patients with <scp>non‐small</scp> cell lung cancer-Reference-Cited by-同舟云学术

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer

Published:2022-11-14 Issue:1 Volume:14 Page:73-80
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Murata Daiki¹^ORCID,Azuma Koichi¹^ORCID,Matama Goushi¹,Zaizen Yoshiaki¹,Matsuo Norikazu¹,Murotani Kenta²,Tokito Takaaki¹^ORCID,Hoshino Tomoaki¹

Affiliation:

1. Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine Kurume University School of Medicine Kurume Japan

2. Biostatistics Center Kurume University School of Medicine Kurume Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14718

Reference29 articles.

1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

2. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

3. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

4. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities;Cancer Immunology, Immunotherapy;2024-09-05

2. Scoring method of English composition integrating deep learning in higher vocational colleges;Scientific Reports;2024-03-27

3. Clinical outcomes of interstitial lung abnormalities: a systematic review and meta-analysis;Scientific Reports;2024-03-27

4. Nivolumab;Reactions Weekly;2024-01-20

5. Pre-Existing Interstitial Lung Abnormalities in Patients with Head and Neck Squamous Cell Carcinoma and Their Follow Up after Therapy;Diagnostics;2023-09-11